Stock listing

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Class A

Selected listing: 600329 · SSE · CNY · CN

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Class A (Shanghai:600329), Health Technology. News releases, investor calls and events on 6ix.

600329:SSECNYCNUpdated October 2, 2026

Ticker: Shanghai:600329
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: Shanghai
Currency: CNY

About Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Class A

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Class A, traded under the ticker 600329, is a public company based in China. The company focuses on the development and production of traditional Chinese medicine and healthcare products.

Latest news from Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Class A

"TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED"Indicative Announcement on Listing and Transfer of 100% Equity Interest in Shanghai Liuliguang Pharmaceutical Development Co., Ltd. by Shanghai Industrial Investment (Holdings) Co., Ltd. and Shanghai Industrial Investment Development Co., Ltd.

September 24, 2026

"TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED"Notice on Convening the 2nd Extraordinary General Meeting in 2026

September 7, 2026

"TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED"Announcement on Resolutions of the 8th Meeting of the Board of Directors in 2026

September 4, 2026

"TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED"Announcement on Convening the 2026 Semi-annual Performance Briefing and Attending the Online Collective Reception Day for Investors of Listed Companies in Tianjin Jurisdiction

August 26, 2026

"TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED"Semi-annual Report for 2026

August 14, 2026

All Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Class A news →

Research Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Class A